Dr. Arshan Dehbozorgi, MD

Dr. Dehbozorgi practices at Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers.

Dr. Dehbozorgi's NPI, 1376072256, was assigned on June 5, 2017. Dr. Dehbozorgi holds Missouri license 2020037119.

Dr. Dehbozorgi's primary practice is Cox Medical Center South, at 3801 South National Avenue, Springfield, MO 65807 in Greene County. The practice phone is (417) 269-6000.

Dr. Dehbozorgi's primary practice is Cox Medical Center South in Springfield, Missouri, part of Lester E. Cox Medical Centers. Dr. Dehbozorgi is also affiliated with Cox Medical Center Branson. The medical group on file is Ferrell-Duncan Clinic. Dmand AI also links Dr. Dehbozorgi to 2 more hospitals and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dehbozorgi practices, 4 sites in all. Vendor and product names are available with a free account.

Diagnostic radiology is Dr. Dehbozorgi's primary specialty in the NPI Registry, under taxonomy code 2085R0202X. Dmand AI has Dr. Dehbozorgi's licenses on file in 2 states: Missouri and Kansas.

CMS data shows 669 Medicare services from Dr. Dehbozorgi across 12 procedure codes in 2024, for 421 Medicare patients. Medicare paid $38,052 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 421 Medicare patients who saw Dr. Dehbozorgi in 2024. The largest group is 65 to 74, with 175 patients. 75% of them have high blood pressure, and 71% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.65, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Dehbozorgi's median patient age at 73, with 41% women.

In 2024, Dr. Dehbozorgi wrote 68 Medicare Part D claims for 24 patients. 100% of them were for generic drugs. CMS names the drug for 39 of them, across 3 drugs with 11 or more claims each, at $152 in total drug cost. In 2022, CMS named 16 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 82 out of 100 for Dr. Dehbozorgi for performance year 2024, reported as part of a group. Dr. Dehbozorgi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 56 general payments to Dr. Dehbozorgi from 16 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 100% of the total. Penumbra, Inc. paid the most, $1,091.